MELASCREEN
Protective Anti-spot Cream SPF50+
MELASCREEN anti-spot cream SPF50+ is the first daily anti-spot treatment with very high protection that prevents and reduces dark spots on a daily basis while protecting the skin from all external aggressions (UVB, short and long UVA, blue light and pollution). Thanks to innovative active ingredients, a double effectiveness has been demonstrated on hyperpigmentation as well as on the first signs of skin ageing for all phototypes. With 27% moisturizing agents, the formula is suitable for dry skin.
-
For whom?WomenPregnant womanBreastfeeding
-
Price
-
TextureMelting texture, non-sticky, water-resistant.
Patient relations
-
Application tips
Apply as often as necessary on the photo-exposed areas (face, neck, décolleté and hands).
To be repeated systematically after swimming or physical activity.
Technology of action
The patented TriAsorB™ (Phenylene bis-diphenyltriazine) sunscreen provides ultra high SPF50+ protection with an ultra broad spectrum protecting the skin from the harmful effects of UVB/UVA radiation and blue light up to 450 nm. This filter does not present any toxicity on species representative of marine biodiversity*.
*Tests carried out on representative species by the Observatoire Océanologique de Banyuls-sur-Mer.
Ingredients
Active ingredients:
Active recognized for its depigmenting, anti-inflammatory and antioxidant properties, dicarboxylic acid naturally present in wheat, rye and barley. It is often used to correct the first signs of ageing.
Active ingredient that nourishes and promotes the replenishment of the skin's protective hydrolipidic film.
Organic sunscreen (Phenylene bis-diphenyltriazine), which protects the skin against DNA damage, prevents skin photo-damage and maintains the integrity of the skin barrier after irradiation.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
Some subjects rated effective to very effective at 2 months (investigator rating) (2).
Reduction in size and intensity of hyperpigmentation at 1 month (3).
Prevention of the appearance of new hyperpigmentation at 1 month (3).
Invisible texture, non-sticky and non-greasy, good make-up base (4).
Tolerance results
Very good skin tolerance (1).
Excellent eye tolerance (1).
Legal Notice
Tolerance and efficacy study in 55 adult women with melasma or lentigo of the face. At least 2 applications per day on the whole face, neck and décolleté during 2 months.
(1) Skin and eye tolerance rated by investigators.
(2) Efficacy perceived by the investigator: % of subjects for whom the product was rated as effective to very effective at 2 months.
(3) % subject satisfaction after 1 month.
Consumer usage test with 100 adult women with facial hyperpigmentation who use a non-tinted SPF50+ photoprotector for dry skin. 3 weeks of application.
(4) cosmetic acceptability questionnaire after 3 weeks.
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Have you noticed any side effects?
The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!
Our commitments
Made in France
Product manufactured in our factories in France.
Conscious Care
Pierre Fabre Laboratories brands, including Ducray Dermatological Laboratories, have joined forces and collectively created Conscious Care: a dermo-cosmetic of the future that acts conscientiously towards its entire ecosystem.
Supporting associations
Ducray Dermatological Laboratories support 14 patient associations around the world, with the objective of sharing information on pathologies to improve their management.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.